相关实验视频

Updated: Sep 17, 2025

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

Published on: August 16, 2024

丸激素对累积细胞基因表达的影响卵巢储备减少的患者

Bruno Tarasconi^1,2, Tatiana C S Bonetti³, Dieli Primo³

¹Departamento de Ginecologia, Escola Paulista de Medicina - Universidade Federal de São Paulo (UNIFESP-EPM), Rua Napoleão de Barros 608, Vila Clementino, São Paulo - SP, CEP 04024-002, Brazil. btarasconi@genesispf.com.br.

Reproductive sciences (Thousand Oaks, Calif.)

|June 30, 2025

概括

对于卵巢储量减少 (DOR) 患者的前治疗降低了细胞中AKT1基因表达的下调. 这可能会在辅助生殖技术中增强卵细胞的生殖潜力.

科学领域:

生殖内分泌学生殖内分泌学
分子生物学分子生物学
辅助生殖技术辅助生殖技术

背景情况:

卵巢储备减少 (DOR) 在辅助生殖技术 (ART) 中提出了挑战.
雄激素在卵泡发育中起着至关重要的作用,影响卵巢功能.
了解雄激素对累积细胞的影响对于改善ART结果至关重要.

研究的目的:

为了研究前治疗对DOR患者累积细胞中的基因表达的影响.
评估丸激素对参与卵泡发育的关键信号通路的影响.

主要方法:

在DOR患者 (42岁以下) 的分层随机化中,将其分为前治疗或对照组.
通过皮肤的丸激素凝 (每天1% 25毫克) 给丸激素组.
累积细胞的RT-qPCR分析,以评估AKT和mTOR信号通路,IGF1,FSHR和AMH中的基因表达.

主要成果:

与对照组相比,前治疗显著降低了细胞中的AKT1基因表达.
两组之间在FOXO1,FOXO3,PTEN,mTOR,TSC1,TSC2,IGF1,FSHR或AMH的表达上没有发现显著差异.
显著的AKT1表达的减少是特异性的丸激素治疗的DOR患者.

结论:

前治疗降低了DOR患者的累积细胞中的AKT1基因表达.
这种下调可能与卵细胞生殖潜力的增强有关.
进一步的研究可以探索改善DOR患者ART成功率的临床影响.

关键词:

在 AKT AKT 里面.累积细胞中的累积细胞.在 MTOR 中,我们可以使用 MTOR.卵巢储备卵巢储备卵巢储备在这里,我们可以看到PTEN.测试激素测试激素是什么

更多相关视频

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

相关概念视频

Oogenesis

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

Infertility in Males

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...

Testosterone: Functions and Regulation

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...

Infertility in Females

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...

Hormonal Control of the Ovarian Cycle

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...

Menopause

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...